Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2010
09/15/2010CN101831442A Preparation method of porcine streptococcus phage perforin
09/15/2010CN101831440A Method for preparing pseudomonas aeruginosa outer membrane protein OprF by prokaryotic expression system
09/15/2010CN101831437A Stress tolerance
09/15/2010CN101831436A Method for breeding adverse-resistant plant
09/15/2010CN101831435A Preparation and application of IL-15 isoform protein of mice
09/15/2010CN101831433A Zebra fish P-selectin gene, encoded protein and application thereof
09/15/2010CN101831432A Biosynthesis method and application of bone morphogenetic protein-2
09/15/2010CN101831411A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
09/15/2010CN101830981A Preparation method of artificial antigen of 4-aminobenzophenone
09/15/2010CN101830980A Chlorothalonil antigen, antibody preparation method and residual chlorothalonil ELISA (Enzyme-Linked Lmmuno Sorbent Assay) detection method
09/15/2010CN101830979A Method for separating and purifying serum albumin by using liquid-solid extraction system
09/15/2010CN101830978A Human immunoglobulin-like receptor mutant and application thereof
09/15/2010CN101830977A Method for purifying recombined human granulocyte stimulating factors
09/15/2010CN101830976A Method for purifying recombined human granulocyte-macrophage stimulating factors
09/15/2010CN101830975A Recombinant galactose agglutinin-1 two-string protein and preparation method thereof
09/15/2010CN101830974A Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof
09/15/2010CN101830973A Rice protein OsAHL and use thereof
09/15/2010CN101830972A Fluorescence complementary system based on green fluorescent protein sfGFP
09/15/2010CN101245110B Recombined leukocyte inhibition factor and hirudo nipponica former peg-and-socket joint protein and pharmaceutical composition
09/14/2010US7795512 Inbred corn line G07-NPID4373
09/14/2010US7795511 Inbred corn line SLB28
09/14/2010US7795502 AtRSp gene promoters
09/14/2010US7795501 Protein regulating leaf longevity of plants, the gene thereof and their use
09/14/2010US7795500 Transgenic plant cell comprising expression vector coding regulatory protein for use in enhancement of drought resistant plants
09/14/2010US7795499 by altered expression of a DR02 nucleic acid; genetic engineering; abiotic stresses
09/14/2010US7795495 utility of beta -synuclein and peptides derived therefrom as anti-amyloidogenic agents ; neurodegenerative diseases such as Alzheimer's and Parkinson's diseases; screening for new anti-amyloidogenic agents
09/14/2010US7795416 Telomerase repressor proteins and nucleic acid compositions encoding the same are provided. The subject repressor proteins bind to a repressor site in the TERT minimal promoter, e.g., a Site C site, and thereby inhibit TERT expression.
09/14/2010US7795415 nucleotide sequences encoding the kinase and conferring stress tolerance to plants upon over-expression; drought resistance
09/14/2010US7795414 Expression vector comprising nucleotide sequences coding lipid metabolism protein (LMP) for use in enhancing seed ability to store lipids, fatty acids and starches; modified seed storage proteins
09/14/2010US7795409 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof
09/14/2010US7795407 Metastatic breast and colon cancer regulated genes
09/14/2010US7795406 Agent for treating leishmania infections
09/14/2010US7795404 modulate cellular activity, regulate the growth and division of cell including stem cells, progenitor and precursor cells
09/14/2010US7795403 Antibodies directed against prothrombin fragment F1+2, the preparation and use thereof
09/14/2010US7795398 for preventing oomycete infection of potato and/or tomato; disease resistant plants; Phytophthora infestans
09/14/2010US7795396 COOH-terminally added cysteine variant of the beta interferon
09/14/2010US7795395 encoding Xenorhabdus toxin complex (TC) proteins; transgenic plants and host cells expressing Xenorhabdus toxin complex (TC) proteins and having resistance to insects; pest control
09/14/2010US7795394 Saitohin gene and uses of same
09/14/2010US7795392 Organic anion transport proteins
09/14/2010US7795391 Protein showing enhanced expression in cancer cells
09/14/2010US7795390 Biological substance nesfatin and its related substances and uses thereof
09/14/2010US7795389 Antagonizing TGF-beta activity with various ectodomains TGF-beta receptors used in combination or as fusion proteins
09/14/2010US7795388 circularly permuted chaperonin peptide molecule, comprising a new carboxyl-terminal amino acid and a new amino-terminal amino acid and a reordered chaperonin polypeptide sequence; can assemble into double-ringed chaperonin structures which can organize into higher order structures such as nanofilaments
09/14/2010US7795387 detecting the decreased transcription of messenger RNA transcribed from an RDCVF1 or RDCVF2 polypeptide, in the eye of a human, wherein said decreased transcription is diagnostic of such human's suffering from retinal dystrohy
09/14/2010US7795386 selectively inhibit alpha v beta 3 integrin; used in the treatment of diseases associated with angiogenesis and cancer
09/14/2010US7795384 expressed with high efficiency and stability in host cells; suitable for high effectively producing short peptides without lysine residues; digesting the fusion protein with trypsinase and carboxypeptidase B, thereby forming peptides C1 and C2
09/14/2010US7795383 interfacial biomaterial (IFBM); coating to promote osteointegration of the implant, accelerating healing; includes peptide that binds to the surface of the implant, and to e.g. bone morphogenic proteins
09/14/2010US7795382 inclusion body tags; Expression of the fusion peptide in a host cell results in a product that is insoluble and contained within inclusion bodies in the cell and/or cell lysate
09/14/2010US7795381 Helper T lymphocytes epitope for use in induction of antitumor responses in melanoma; antiproliferative agents
09/14/2010US7795378 Erectile dysfunction
09/14/2010US7795225 inhibitors of chondrosarcoma cell growth that are useful as anti-cancer and anti-tumor agents; inhibitors are peptides having sequences related to cleavage regions of the proenzyme forms of matrix metalloproteinases and that can inhibit the activity of matrix metalloproteinases
09/14/2010US7795224 Tumor associated antigen peptides and use of same as anti-tumor vaccines
09/14/2010US7795223 Treatment of inflammatory airway disease
09/14/2010US7795222 administering peptide comprising claimed amino acid sequence; insulin-like growth factor; therapy for vision defects, skin disorders; wound healing agents; antiulcer agents
09/14/2010US7795220 biologically active peptide for use in limiting undesired bone loss in a vertebrate at risk of such bone loss, in treating conditions that are characterized by undesired bone loss or by the need for bone growth, e.g. in treating fractures or cartilage disorders and for raising camp levels in cells
09/14/2010US7795218 Biodrugs comprising polypeptides and carriers comprising bioadhesives such as fibrin, for treatment of vision defects; chimeric C3-like Rho antagonists and their use for promoting repair and neuron survival in injured mammalian central and peripheral nervous system and for treating cancer
09/14/2010US7795215 MNTF peptides and compositions and methods of use
09/14/2010US7795214 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases
09/14/2010US7795212 such as viral myocarditis (Coxsackie virus, echovirus, polio virus) or dilated (congestive) cardiomyopathy, by binding ErbB2-ErbB4 receptors; atpase inhibitors
09/14/2010US7795211 Overexpression of protease hepsin; induce immunology response; inoculation with hepsin peptide; monitoring immunotherapy
09/14/2010US7795210 Protein remodeling methods and proteins/peptides produced by the methods
09/14/2010US7795209 Anti-angiogenic methods and compositions
09/14/2010US7795206 Peptide that inhibits janus kinase
09/14/2010US7795202 Inducing the migration of progenitor cells into regions of nervous tissue damage; identify region of nervous tissue damage, incubate with progenitor cells and transforming growth factor, monitor therapeutic response; repair of nervous system injuries or neurodegenerative disorders; tissue repair
09/14/2010US7795042 red-emitting fluorescent rhodamine dyes; photostable; useful as molecular probes; For use in assays involving staining of cells, protein binding, and/or analysis of nucleic acids (hybridization and sequencing)
09/14/2010US7795032 Methods for proliferating cardiomyocytes and recombinant vectors therefor
09/14/2010US7795028 Modulating developmental transitions in plants
09/14/2010US7795017 plasmid constructs useful for the delivery of DNA vaccines; having a transcription cassette capable of directing the expression of a vaccine nucleic acid insert encoding immunogens derived from any pathogen, including fungi, bacteria and viruses
09/14/2010US7795016 P185 Neu-encoding DNA and therapeutical uses thereof
09/14/2010US7794993 Carbonyl reductase, gene thereof and method of using the same
09/14/2010US7794992 Enzymatic synthesis, modification and degradation of silicon(IV)- and other metal(IV)-compounds
09/14/2010US7794980 comprising an autoprocessing segment having an amino acid sequence being capable of auto-cleavage
09/14/2010US7794977 Using transgenic cell comprising stabilizing-antirepression sequences (STAR) a bioreactor for production of preferential polypeptides
09/14/2010US7794975 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
09/14/2010US7794974 Fungal transcriptional activators useful in methods for producing a polypeptide
09/14/2010US7794973 Nucleotide sequences coding protein for use in the treatment of blood disorders; cDNA derived from mouse yolk sacs
09/14/2010US7794972 Benzoate-and anthranilate-inducible promoters
09/14/2010US7794964 Biochip for the detection of phosphorylation and the detection method using the same
09/14/2010US7794959 bioassay for identifying a compound which blocks or inhibits bitter taste elicited by one or more bitter compounds present in hydrolyzed soy protein by the activation of a human T2R bitter taste receptor ; eating disorders, food sensing, food absorption, obesity, diabetes, Crohn's disease, celiac disease
09/14/2010US7794957 Eukaryotic genes involved in adult lifespan regulation
09/14/2010US7794955 Transfecting a eukaryotic cell with nucleotide sequence, contacting cell with a candidate compound; determining distribution of expressed protein in cell by detecting the distribution of detectable moiety in cell; drug screening for their ability to interact with transmembrane proteins
09/14/2010US7794930 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds
09/14/2010US7794927 Method for identifying agonists or antagonists of the G-protein coupled receptor mas-like 1
09/14/2010US7794926 diagnosing cancer detecting the presence of survivin in urine samples; kits
09/14/2010US7794756 Methods of using antibodies to VEGF-C
09/14/2010US7794754 Methods for fine powder formation
09/14/2010US7794735 Pathogen for bacterial poultry disease
09/14/2010US7794734 for immunizing cattle against infection from Mannheimia haemolytica; vaccine having purified recombinant PlpE outer membrane protein of Mannheimia with adjuvant; veterinary medicine
09/14/2010US7794733 Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis, compositions containing same and methods of use thereof
09/14/2010US7794731 Use of flagellin in the immunotherapy of Yersinia pestis
09/14/2010US7794729 Administering a Listeria vaccine with a strain expressing an antigen fused to a truncated LLO protein; cancer vaccines; anticarcinogenic agents
09/14/2010US7794728 Induction immunology response; vaccines
09/14/2010US7794726 based on a native version of the enzyme from E. corrodens and induces production of antibodies that inhibit the activity of the lysine decarboxylase enzyme in the oral cavity; comprising a substitution at a position corresponding to position 365 of SEQ ID NO:2
09/14/2010US7794725 Isolated peptides derived from human immunodeficiency virus types 1 and 2 containing fusion inhibitory domains
09/14/2010US7794719 variable regions peptides for immunizing against amyloid plaque formation; biodrug for dementia, Alzheimer's disease, neuropathy, Down's syndrome, Creutzfeld Jacob disease, Parkinson's disease, amyotropic lateral sclerosis; neuroprotectants; hemostatic agent
09/14/2010US7794718 fusion protein comprising polypeptide with a human immunoglobulin (Ig) polypeptide; has an ability to bind CD80 or CD86 or an extracellular domain of either CD80 or CD86, and/or an ability to inhibit a T cell immune response
09/14/2010US7794702 Expression vector for use as gene transfer tool in treatment of cardiovascular disorders
09/14/2010CA2633573C Inhibition of tau-tau-association
09/14/2010CA2484525C Maize clavata3-like polynucleotide sequences and methods of use
09/14/2010CA2386231C Membrane translocating peptide drug delivery system